Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Navid Shomali

Showing results (41-50 of 75) with videos related to

Pageof 8
Sort By:
Cellular & Molecular Biology Letters|July 16, 2022
Therapeutic utility of mesenchymal stromal cell (MSC)-based approaches in chronic neurodegeneration: a glimpse into underlying mechanisms, current status, and prospectsMohaddeseh Rahbaran, Angelina Olegovna Zekiy, Mahta Bahramali, et al.
Frontiers in Immunology|March 21, 2022
Dysregulation of Survivin-Targeting microRNAs in Autoimmune Diseases: New Perspectives for Novel TherapiesNavid Shomali, Marwah Suliman Maashi, Behzad Baradaran, et al.
Iranian Journal of Immunology : IJI|September 26, 2019
Effects of CD133 Silencing on Survival and Migration of HT-29 Colorectal Cancer CellsMorteza Akbari, Dariush Shanehbandi, Milad Asadi, et al.
Cell Communication and Signaling : CCS|January 19, 2024
New immunotherapy approaches for colorectal cancer: focusing on CAR-T cell, BiTE, and oncolytic virusesAmin Kamrani, Hadi Nasiri, Ali Hassanzadeh, et al.
International Immunopharmacology|November 13, 2020
Gut microbiome and multiple sclerosis: New insights and perspectiveMohammad Esmaeil Amini, Navid Shomali, Arash Bakhshi, et al.
IUBMB Life|July 21, 2020
miR-143 acts as an inhibitor of migration and proliferation as well as an inducer of apoptosis in melanoma cancer cells in vitroSeyed Ali Nabipoorashrafi, Navid Shomali, Leila Sadat-Hatamnezhad, et al.
IUBMB Life|September 19, 2021
PD-1/PD-L1 blockade: Prospectives for immunotherapy in cancer and autoimmunityRamin Hosseinzadeh, Fahimeh Feizisani, Navid Shomali, et al.
Cellular & Molecular Biology Letters|May 5, 2022
CRISPR/Cas9 application in cancer therapy: a pioneering genome editing toolSadegh Shojaei Baghini, Zhanna R Gardanova, Saeme Azizi Hassan Abadi, et al.
BMC Research Notes|December 30, 2020
Epigenetic mechanisms shape the underlining expression regulatory mechanisms of the STAT3 in multiple sclerosis diseaseArezoo Hosseini, Zohreh Babaloo, Tohid Gharibi, et al.
Life Sciences|July 14, 2023
Pattern-recognition receptors (PRRs) in SARS-CoV-2Alireza Isazadeh, Javad Ahmadian Heris, Parviz Shahabi, et al.
Pageof 8

Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
Cellular & Molecular Biology Letters|July 16, 2022
Therapeutic utility of mesenchymal stromal cell (MSC)-based approaches in chronic neurodegeneration: a glimpse into underlying mechanisms, current status, and prospectsMohaddeseh Rahbaran, Angelina Olegovna Zekiy, Mahta Bahramali, et al.
Frontiers in Immunology|March 21, 2022
Dysregulation of Survivin-Targeting microRNAs in Autoimmune Diseases: New Perspectives for Novel TherapiesNavid Shomali, Marwah Suliman Maashi, Behzad Baradaran, et al.
Iranian Journal of Immunology : IJI|September 26, 2019
Effects of CD133 Silencing on Survival and Migration of HT-29 Colorectal Cancer CellsMorteza Akbari, Dariush Shanehbandi, Milad Asadi, et al.
Cell Communication and Signaling : CCS|January 19, 2024
New immunotherapy approaches for colorectal cancer: focusing on CAR-T cell, BiTE, and oncolytic virusesAmin Kamrani, Hadi Nasiri, Ali Hassanzadeh, et al.
International Immunopharmacology|November 13, 2020
Gut microbiome and multiple sclerosis: New insights and perspectiveMohammad Esmaeil Amini, Navid Shomali, Arash Bakhshi, et al.
IUBMB Life|July 21, 2020
miR-143 acts as an inhibitor of migration and proliferation as well as an inducer of apoptosis in melanoma cancer cells in vitroSeyed Ali Nabipoorashrafi, Navid Shomali, Leila Sadat-Hatamnezhad, et al.
IUBMB Life|September 19, 2021
PD-1/PD-L1 blockade: Prospectives for immunotherapy in cancer and autoimmunityRamin Hosseinzadeh, Fahimeh Feizisani, Navid Shomali, et al.
Cellular & Molecular Biology Letters|May 5, 2022
CRISPR/Cas9 application in cancer therapy: a pioneering genome editing toolSadegh Shojaei Baghini, Zhanna R Gardanova, Saeme Azizi Hassan Abadi, et al.
BMC Research Notes|December 30, 2020
Epigenetic mechanisms shape the underlining expression regulatory mechanisms of the STAT3 in multiple sclerosis diseaseArezoo Hosseini, Zohreh Babaloo, Tohid Gharibi, et al.
Life Sciences|July 14, 2023
Pattern-recognition receptors (PRRs) in SARS-CoV-2Alireza Isazadeh, Javad Ahmadian Heris, Parviz Shahabi, et al.
Pageof 8